XML 62 R50.htm IDEA: XBRL DOCUMENT v3.19.3
Equity Changes in stockholders' equity (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Oct. 31, 2019
Jul. 31, 2019
Apr. 30, 2019
Oct. 31, 2018
Jul. 31, 2018
Apr. 30, 2018
Oct. 31, 2019
Oct. 31, 2018
Jan. 31, 2019
Jan. 31, 2018
Feb. 01, 2018
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Beginning of period $ 225,139 $ 234,160 $ 84,549 $ 85,583 $ 88,565 $ 81,453 $ 84,549 $ 81,453 $ 81,453    
Common stock offering, net of issuance costs of $530     146,470       $ 146,470        
Exercise of stock options (in shares)             2,572,241        
Exercise of stock options 3,406 4,137 4,996 4,942 5,232 4,910 $ 12,539   18,862    
Vested restricted stock units converted to common shares 0 0 0 0 0 0 0   0    
Issuance of restricted stock   0 0   0 0 0   0    
Issuance of common stock under employee stock purchase plan 3,344   3,283 2,687   4,091 6,627   6,778    
Stock-based compensation 21,601 17,025 13,472 13,218 11,081 8,066 52,098   44,907    
Other comprehensive income 1,583 (892) 349 182 101 (95) 1,040   205    
Net loss (42,717) (29,291) (18,959) (22,940) (19,396) (17,041) (90,967) (59,377) (74,837)    
Cumulative effect adjustment in connection with the adoption of ASU 2014-09                     $ 7,181
End of period $ 212,356 $ 225,139 $ 234,160 $ 83,672 $ 85,583 $ 88,565 212,356 $ 83,672 $ 84,549 $ 81,453  
Issuance costs             $ 500        
Common Stock                      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Beginning of period (in shares) 112,682,000 111,000,000 102,173,000 98,461,000 96,238,000 93,977,000 102,173,000 93,977,000 93,977,000    
Beginning of period $ 119 $ 117 $ 109 $ 105 $ 103 $ 100 $ 109 $ 100 $ 100    
Common stock offering, net of issuance costs (in shares)     7,000,000       7,000,000        
Common stock offering, net of issuance costs of $530     $ 7       $ 7        
Exercise of stock options (in shares) 647,000 830,000 1,096,000 1,489,000 1,833,000 1,678,000 2,573,000   5,901,000    
Exercise of stock options $ 0 $ 1 $ 1 $ 1 $ 1 $ 2 $ 2   $ 5    
Vested restricted stock units converted to common shares (in shares) 820,000 845,000 557,000 566,000 378,000 141,000 2,222,000   1,585,000    
Vested restricted stock units converted to common shares $ 1 $ 1   $ 1 $ 1   $ 2   $ 3    
Issuance of restricted stock (in shares)   7,000 4,000   12,000 4,000 11,000   16,000    
Issuance of common stock under employee stock purchase plans (in shares) 222,000   170,000 256,000   438,000 392,000   694,000    
Issuance of common stock under employee stock purchase plan     $ 0     $ 1     $ 1    
End of period (in shares) 114,371,000 112,682,000 111,000,000 100,772,000 98,461,000 96,238,000 114,371,000 100,772,000 102,173,000 93,977,000  
End of period $ 120 $ 119 $ 117 $ 107 $ 105 $ 103 $ 120 $ 107 $ 109 $ 100  
Additional Paid-in Capital                      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Beginning of period 588,255 567,095 398,882 361,719 345,408 328,344 398,882 328,344 328,344    
Common stock offering, net of issuance costs of $530     146,463       146,463        
Exercise of stock options 3,406 4,136 4,995 4,941 5,231 4,908 12,537   18,857    
Vested restricted stock units converted to common shares (1) (1)   (1) (1)   (2)   (3)    
Issuance of common stock under employee stock purchase plan 3,344   3,283 2,687   4,090 6,627   6,777    
Stock-based compensation 21,601 17,025 13,472 13,218 11,081 8,066 52,098   44,907    
End of period 616,605 588,255 567,095 382,564 361,719 345,408 616,605 382,564 398,882 328,344  
Issuance costs     530             530  
Accumulated Other Comprehensive Loss                      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Beginning of period (1,971) (1,079) (1,428) (1,627) (1,728) (1,636) (1,428) (1,636) (1,636)    
Other comprehensive income 1,583 (892) 349 182 101 (95) 1,040   205    
Cumulative effect adjustment in connection with the adoption of ASU 2014-09                     3
End of period (388) (1,971) (1,079) (1,445) (1,627) (1,728) (388) (1,445) (1,428) (1,636)  
Accumulated Deficit                      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Beginning of period (349,359) (320,068) (301,109) (262,709) (243,313) (233,450) (301,109) (233,450) (233,450)    
Net loss (42,717) (29,291) (18,959) (22,940) (19,396) (17,041) (90,967)   (74,837)    
Cumulative effect adjustment in connection with the adoption of ASU 2014-09                     $ 7,178
End of period (392,076) (349,359) (320,068) (285,649) (262,709) (243,313) (392,076) (285,649) (301,109) (233,450)  
Treasury Stock                      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Beginning of period (11,905) (11,905) (11,905) (11,905) (11,905) (11,905) (11,905) (11,905) (11,905)    
End of period $ (11,905) $ (11,905) $ (11,905) $ (11,905) $ (11,905) $ (11,905) $ (11,905) $ (11,905) $ (11,905) $ (11,905)